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The literature describes 15 cases of congenital pancreatoblastoma (PB): 5 had prenatal diagnosis, none
had metastases at diagnosis, 7 were associated with BeckwitheWiedemann syndrome (BWS). In 13 cases
resection was radical, while in 2 there were macroscopic residues. Only one patient underwent
chemotherapy after distant recurrence. All children are alive except one who died because of problems
related to BWS. Our goal is to describe the approach adopted in an infant with congenital PB treated in
our center. After a prenatal third semester diagnosis of abdominal anechoic lesion, the radiological in-
vestigations (ultrasound, MRI) performed at birth described a cystic lesion of unclear nature. We pro-
ceeded to laparoscopic exploration, transformed into open approach after the detection of a lesion
located in the body of the pancreas; this lesion was resected, preserving the head and tail of pancreas.
The histological diagnosis showed a completely excised PB. After excluding metastatic lesions, we
decided to perform only careful follow-up without chemotherapy. The follow-up at 12 months is
negative. Although PB is a malignant tumor that requires a multidisciplinary treatment, the congenital
cases seem to have a less aggressive biological behavior. The treatment, therefore, in case of complete
resection, could be only surgical, followed by a careful follow-up. These forms are often associated with
congenital BWS, but in our case the patient did not have the typical characteristics of the syndrome.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Pancreatoblastoma (PB) is a pancreatic malignant tumor.
Although rare, with approximately 200 cases reported in literature
[1], it is one of the most common pancreatic exocrine tumors in
childhood [2].
The congenital form, deﬁned as tumors detected before 3
months of age, is even less common. To date, 15 cases are reported
worldwide, summarized in Table 1 [1,3].
aFP: a-fetoprotein; DOD: died of disease; GA: gestational age; N/
A: not applicable; NED: no evidence of disease.[legend; see in-
struction]We report a case of congenital PB with prenatal diagnosis
treated in our Center.1. Case report
Prenatal diagnosis, at last trimester ultrasonography (US),
described an anechoic lesion (40  40 mm) with intracystic,c. This is an open access article undehyperechoic lesions, 18 24 and 6 5mm respectively, developing
in front of the left kidney.
The gestation was regular, and at birth the child was asymp-
tomatic. No family factors were reported. After birth the patient
underwent the following investigations:
- Abdominal US, performed at 2 days of life, conﬁrmed the
presence of a round lesion in the left upper abdominal quad-
rant, measuring 4.5  4.5  4 cm, containing approximately
42 ml of ﬂuid; the walls presented two solid hypo-echogenic
portions projecting into the lumen, of 20 and 7 mm respec-
tively, the ﬁrst with internal vascularization. This lesion
seemed to be separated from the left kidney, spleen, and
stomach, occupying the region of the pancreatic tail, with an
otherwise normal pancreas, and it was unclear if this formation
had a mesenteric, pancreatic or left adrenal origin.
- Abdominal MRI with contrast, performed at 8 days of life,
identiﬁed a 5.1  4.6  5.5 cm round lesion located in the
epigastrium, below the stomach and anterior to the body of the
pancreas. It was not possible to visualize a plane between the
pancreatic parenchyma and the lesion; the head and bodyr the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Congenital PB cases reported in literature.
Age Presentation Sex Tumor
location
Tumor
size (cm)
aFP Complete
surgical
resection
Postsurgical
treatment
Outcome BWS Reference
20 wk GA Abnormal US (cyst) F Head 11 Increased Yes None NED, 2 y Yes [1]
28 wk GA Abnormal US (cyst) M Body-Tail 4 Normal Yes None NED, 26 mo Yes [1]
30 wk GA Abnormal US (cyst) M Body 5.5 Normal Yes None NED, 1 y Current report
30 wk GA Abnormal US (cyst) M Body-Tail 4.2 Normal Yes None NED, 10 mo No [1]
30 wk GA Abnormal US M Tail 7 Unknown Yes None NED, 10 mo Yes [1]
34 wk GA Abnormal US (cyst) F Body-Tail 4 Normal Yes None NED, 15 mo No [1]
Newborn Incidental ﬁnding F Head 1.5 Unknown N/A None Stillborn No [1]
20 h Mass M Body 10 Unknown N/A None DOD at 12 d Yes [1]
3 d Jaundice M Body-Tail 7.5 Increased Yes None NED, 3 y No [1]
3 d Palpable mass M Unknown Unknown Increased Yes None Unknown No [3]
19 d Mass M Body 7.5 Unknown No None NED, 4 y Yes [1]
3 wk Irritability, Jaundice M Head 6 Unknown Yes None NED, 10 y No [1]
6 wk Palpable mass M Tail 5 Unknown Yes None NED, 29 y Yes [1]
2 mo Hemihypertrophy M Head 4.5 Increased Yes None NED, 5 y Yes [1]
3 mo Incidental ﬁnding F Head 10.5 Unknown No Chemotherapy Recurred at
7 mo; NED at 68 mo
No [1]
3 mo Mass F Tail 8 Unknown Yes None NED, 39 mo No [1]
aFP: a-fetoprotein; DOD: died of disease; GA, gestational age; N/A, not applicable; NED, no evidence of disease.
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(about 2e3 mm) with at least 4 solid thickenings of 10 and
22 mm. After contrast injection both the wall and the solid
thickenings were enhancing (Fig. 1).
The initial diagnostic impression was that of a mesenteric cyst,
and, at the age of 21 days, the patient was admitted by our Center, to
be operated on.
The operation was ﬁrst carried on with a minimally-invasive
technique. During exploration of the abdomen, the lesion, with
mixed solid and cystic appearance, was clearly originating from the
body of the pancreas. The laparoscopic approach was aborted, and
the tumor was completely excised through an open laparotomy
(Fig. 2). When it was removed, part of the inferior body remained as
a bridge between head and tail of pancreas. Since we were not
completely conﬁdent the duct was sectioned, it was decided not to
resect the whole distal part of pancreas.
The histological diagnosis was pancreatoblastoma.
Cancer markers were evaluated: aFP values were always be-
tween the age range, and consistently decreased over time
(9107 ug/L at d23, 5734 ug/L at d29, 1126 ug/L at d45); HCG and CEA
values were negative. After surgery, the patient underwent onco-
logic staging with a chest and abdominal CT scan. Metastatic dis-
ease was excluded and, according to the management described in
literature for congenital cases, it was decided to perform only a
careful follow-up without adjuvant chemotherapy.
The follow-up at 12 months is negative.Fig. 1. MRI.2. Discussion
The initial differential diagnosis of congenital abdominal cystic
lesions includes malformations (enteric duplication cyst, mesen-
teric cyst) and neoplastic lesions (teratoma, neuroblastoma). Even if
rare, PB should be considered in the differential diagnosis.
The radiologic diagnosis of PB can be difﬁcult, and even in large
primary tumors, it is not always possible to identify the pancreas as
the organ of origin. At US, PB presents heterogenous echogenicity,
often with hypoechoic cysts and echogenic septa; MRI and CT scan
can help in deﬁning localization and the intrinsic characteristics,
such as presence of necrosis, septa or calciﬁcations [4].
To date, 15 cases of congenital PB are described in literature. One
third (5/15) of them had a prenatal diagnosis, and none had me-
tastases at diagnosis. An important association with BWS was re-
ported, involving almost half of the patient (7/15).
PB is a malignant tumor that requires a multidisciplinary
treatment. Chemotherapy including cisplatin and anthracyclines,
similar to that used for hepatoblastoma, seems to be the most
appropriate treatment. However, the 5-year survival still remains
unsatisfactory. Prognosis remains linked to the possibility of a
radical resection and the absence of metastases [5].
All the congenital cases described in literature underwent initial
surgical treatment: in 13 patients the resection was radical, while
macroscopic residues were present in 2 children. The patients withFig. 2. PB at laparotomy.
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radiotherapy. In one patient only, who had incomplete initial sur-
gical resection, chemotherapy was utilized because of local recur-
rence at 7 months from diagnosis [1,6].
3. Conclusion
The congenital cases described in literature present higher as-
sociation with congenital BWS than pediatric and adult cases;
however in half cases congenital PB was isolated.
Despite the aggressive biological behavior in children, the
congenital cases seem to have a more benign course. Therefore, in
case of complete resection, the treatment should be only surgical,
followed by a close follow-up. Cases however are rare, and larger
series are probably needed to conﬁrm a conservative approach.References
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